Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Operating Leases (2017 - 2025)

AC Immune (ACIU) has disclosed Operating Leases for 8 consecutive years, with $4.6 million as the latest value for Q4 2025.

  • Quarterly Operating Leases fell 8.13% to $4.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.6 million through Dec 2025, down 8.13% year-over-year, with the annual reading at $4.6 million for FY2025, 8.13% down from the prior year.
  • Operating Leases for Q4 2025 was $4.6 million at AC Immune, down from $5.0 million in the prior quarter.
  • The five-year high for Operating Leases was $5.0 million in Q4 2024, with the low at $2.3 million in Q4 2022.
  • Average Operating Leases over 5 years is $3.5 million, with a median of $3.2 million recorded in 2023.
  • The sharpest move saw Operating Leases surged 57.75% in 2024, then dropped 8.13% in 2025.
  • Over 5 years, Operating Leases stood at $2.5 million in 2021, then dropped by 7.84% to $2.3 million in 2022, then soared by 36.18% to $3.2 million in 2023, then soared by 57.75% to $5.0 million in 2024, then dropped by 8.13% to $4.6 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $4.6 million, $5.0 million, and $3.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.